Skip to main content
. 2020 May 18;8(2):233. doi: 10.3390/vaccines8020233

Table 1.

Characteristics of pneumococcal conjugate vaccines (PCVs; PCV13, PCV10 A and PCV10 B).

Characteristics PCV13 PCV10 A PCV10 B
1 Dose/Vial 4 Dose/Vial 4 Dose/Vial 1 Dose/Vial 5 Dose/Vial
Serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F 1, 5, 6A, 6B, 7F, 9V, 14, 19A, 19F, 23F
WHO Prequalification 2010 2016 2017 2020 2020
Price per dose $3.30 */$20.83 ** $2.90 * $3.05 * $3.50 * $2.00 *
Doses per fully immunized child 3 3 3 3 3
Indicative wastage rate 5% 8% 8% 5% 8%
Shelf-life 36 months at 2–8 ℃ 36 months at 2–8 ℃ 36 months at 2–8 ℃ 36 months at 2–8 ℃ 36 months at 2–8 ℃
Cold chain volume per dose *** 12.6 cm³ 3.9 cm³ 2.7 cm³ 17.0 cm³ 3.7 cm³
Cost of cold room (per cm³) **** $0.0013 $0.0013 $0.0013 $0.0013 $0.0013
Handling open vials N.A. Opened vials may be kept for use in subsequent immunization sessions (up to 28 days from the withdrawals of the first injection if held at 2 to 8 ℃) Opened vials may be kept for use in subsequent immunization sessions (up to 28 days from the withdrawals of the first injection if held at 2 to 8 ℃) N.A. Opened vials may be kept for use in subsequent immunization sessions (up to 28 days from the withdrawals of the first injection if held at 2 to 8 ℃)

N.A. = Not applicable; * Gavi-AMC price with procurement via UNICEF SD [25]; ** Government contract price of PCV13; *** According to Gavi’s latest report [24]; **** According to a study by Parmar et al. and WHO Performance, Quality and Safety (PQS) standards [26,27].